Mesdopetam clinical trials
Also written IRL790.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How each study uses mesdopetam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Integrative Research Laboratories AB (3)
Studies
Open first, then newest update. How each study uses mesdopetam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced DyskinesiaCompletedPhase 2Integrative Research Laboratories ABNCT04435431Written as Mesdopetam
- Efficacy and Tolerability of IRL790 in Parkinson's Disease DyskinesiaCompletedPhase 2Integrative Research Laboratories ABNCT03368170Written as Mesdopetam (IRL790)
- A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced DyskinesiaCompletedPhase 1/2Integrative Research Laboratories ABNCT03531060Written as IRL790
Codes
What other systems call mesdopetam · ClinicalTrials.gg INT001856
- MeSH (NLM) C000722506mesdopetamOne source ClinicalTrials.gov
- UNII (FDA) HD4QV8GX26MESDOPETAMConfirmed FDA, Wikidata
- Wikidata Q105337538mesdopetamConfirmed FDA, Wikidata
- NCI Thesaurus C175816MesdopetamOne source FDA
- DrugBank DB16229One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000722506 | mesdopetam | One source ClinicalTrials.gov |
| UNII (FDA) | HD4QV8GX26 | MESDOPETAM | Confirmed FDA, Wikidata |
| Wikidata | Q105337538 | mesdopetam | Confirmed FDA, Wikidata |
| NCI Thesaurus | C175816 | Mesdopetam | One source FDA |
| DrugBank | DB16229 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.